May 1, 2024- AdventHealth, which has 95,000 team members, has a multi-pronged strategy for upskilling and training the workforce, according to AdventHealth and Becker's Hospital Review. The health system has been focused on replenishing the system's workforce and leadership pipeline over the last few years. AdventHealth offers education assistance, clinical ladder … [Read more...]
Guidance released for navigating supply chain disruptions caused by faulty syringes from China
May 1, 2024- ECRI, a global safety nonprofit, has shared recommendations about mitigating the threats posed by malfunctioning syringes manufactured in China. In an ECRI Exclusive Hazard Report from December 2023, ECRI advised its members to review their inventory of all plastic syringes to identify those made in China; contact vendors to request the original equipment … [Read more...]
Humana Healthy Horizons commits to improving health of Louisianians
April 30, 2024- Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana, Inc. announced that it will invest this year in support of community organizations across Louisiana. The investment dollars have been disbursed to 24 nonprofit organizations that share the company’s passion for overcoming public health challenges and improving … [Read more...]
U.S. FDA approves Pfizer’s BEQVEZ™, a one-time gene therapy for adults with hemophilia B
April 30, 2024- Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX (FIX) prophylaxis therapy, or have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes, and … [Read more...]
Forbes announces best employers for diversity
April 30, 2024- To recognize employers that have continued to prioritize DEI this past year, Forbes has ranked America’s Best Employers For Diversity 2024. Numerous renowned companies in the healthcare industry have made the list including Pfizer, Cook Children's Healthcare System, Humana, Vizient, Thermo Fisher, Children's Hospital of Colorado, and many more. This seventh … [Read more...]
Afib more common and dangerous in younger people than previously thought
April 30, 2024- Atrial fibrillation (Afib), a common type of arrhythmia that is on the rise in people under the age of 65, is more dangerous in this increasingly younger population than previously thought, according to a new study published in Circulation Arrhythmia and Electrophysiology and authored by physician-scientists at the UPMC Heart and Vascular … [Read more...]
Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator
April 30, 2024- Medtronic plc announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in … [Read more...]
Abbott receives FDA approval for first-of-its-kind dissolvable stent
April 29, 2024- Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to … [Read more...]
OJEMDA™ (tovorafenib), FDA approved for Pediatric Low-Grade Glioma, available at Biologics by McKesson
April 29, 2024- Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease, was selected by Day One Biopharmaceuticals, as a limited network specialty pharmacy for OJEMDATM (tovorafenib) for the treatment of pediatric low-grade glioma (pLGG). OJEMDA, granted Rare Pediatric Disease Designation and approved by the U.S. Food and Drug … [Read more...]
Cardinal Health expands distribution footprint
April 29, 2024- Cardinal Health recently took a significant step to bolster domestic medical product storage capabilities in Canada with the opening of a new 163,000 square-foot distribution center in Ontario, increasing the distribution footprint in Canada to more than 1.2 million square feet. It is also the first facility fully dedicated to Cardinal Health’s ValueLink® … [Read more...]